Friedland Jeffrey 4
4 · NEXIEN BIOPHARMA, INC. · Filed May 1, 2019
Insider Transaction Report
Form 4
Friedland Jeffrey
DirectorChief Executive Officer10% Owner
Transactions
- Sale
Common Stock
2019-04-04$0.09/sh−5,000,000$425,000→ 19,000,000 total(indirect: By Kanativa USA Inc.)
Holdings
- 833,333
Common Stock
- 228,800(indirect: By LLC)
Common Stock
Footnotes (3)
- [F1]The Reporting Person disclaims all beneficial ownership of the securities owned by Kanativa USA Inc., and this report shall not be deemed an admission of beneficial ownership of such securities by the Reporting Person.
- [F2]Kanativa USA Inc. sold 5,000,000 shares effective April 4, 2019.
- [F3]In exchange for the sale of the 5,000,000 shares of common stock, Kanativa USA Inc. received 8,500,000 shares of common stock of Phyto Brands Inc., which valued the shares of Nexien BioPharma Inc. at $0.085 per share.